Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Thomas Matthias Scherzer"'
Autor:
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, Philipp Pimingstorfer, Silke Suesse, Thomas-Matthias Scherzer, Bernhard Paulweber, Peter Ferenci, Thomas Stimpfl, Michel Yegles, Christian Datz, Michael Trauner
Publikováno v:
Journal of Hepatology. 78:1080-1083
Autor:
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, Philipp Pimingstorfer, Silke Suesse, Thomas-Matthias Scherzer, Bernhard Paulweber, Peter Ferenci, Thomas Stimpfl, Michel Yegles, Christian Datz, Michael Trauner
Publikováno v:
Journal of hepatology. 77(4)
Non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) cannot reliably be distinguished by routine diagnostics, and the role of alcohol consumption in metabolic dysfunction-associated fatty liver disease (MAFLD) remains unc
Publikováno v:
Zeitschrift für Gastroenterologie. 55:e28-e56
Autor:
M. Trauner, Harald Hofer, B Meyer, Peter Ferenci, M Teufelhart, Thomas-Matthias Scherzer, B Mehl, S Nistler, Helmuth Haslacher, C Rabitsch, R Winker
Publikováno v:
Zeitschrift für Gastroenterologie. 55:e28-e56
Autor:
Daniel Reichhold, Thomas-Matthias Scherzer, Peter Ferenci, Daniela Ferenci-Förster, Michael Hagmann, Gabriele Moser, Katharina Staufer, Wolfgang Miehsler, Christian Kienbacher
Publikováno v:
Antiviral Therapy. 20:501-506
Background Interferon (IFN)-induced depression occurs in approximately 30% of chronic hepatitis C (CHC) patients undergoing pegylated (PEG)-IFN-based antiviral therapy. While IFN-free therapy has been developed, it is not accessible to all CHC patien
Autor:
Hermann Laferl, Harald Hofer, Karoline Rutter, Sandra Beinhardt, Rudolf E. Stauber, Christian Datz, Albert Friedrich Stättermayer, Peter Ferenci, Michael Strasser, Andreas Maieron, Petra Steindl-Munda, Remy Schwarzer, Thomas-Matthias Scherzer
Publikováno v:
Journal of Hepatology. 59:964-971
Background & Aims Single nucleotide polymorphisms (SNPs) in the inosine triphosphate pyrophosphatase ( ITPA ) gene protect patients from ribavirin induced anemia. To investigate other possible protective cofactors, gender differences were analyzed in
Autor:
M. Dulic, Harald Hofer, Karoline Rutter, Andreas Maieron, AF Stättermayer, Heidemarie Holzmann, Robert Strassl, Petra Steindl-Munda, Peter Ferenci, Sandra Beinhardt, Hermann Laferl, Thomas-Matthias Scherzer, Michael Gschwantler
Publikováno v:
Alimentary Pharmacology & Therapeutics. 38:118-123
BACKGROUND The introduction of direct-acting anti-virals has increased sustained virological response (SVR) rates in chronic hepatitis C genotype 1 infection. At present, data on long-term durability of viral eradication after successful triple thera
Autor:
M. Trauner, Peter Ferenci, Thomas-Matthias Scherzer, Harald Hofer, B Mehl, M Teufelhart, C Rabitsch, R Winker, Helmuth Haslacher
Publikováno v:
Zeitschrift für Gastroenterologie. 54
Autor:
Thomas-Matthias Scherzer, Berit A. Payer, Peter Ferenci, P. M. Heil, Markus Peck-Radosavljevic, Armin Rieger, Maximilian C. Aichelburg, Thomas Reiberger, Christopher Schuster, F Breitenecker
Publikováno v:
Journal of Infection. 65:142-149
OBJECTIVES: Antiviral treatment with pegIFN/RBV decreases ANC and CD4+ cell count. An association between neutropenia, a low CD4+ cell count and infections has not been demonstrated so far in HIV-HCV coinfected patients. METHODS: The incidence, type,
Autor:
Thomas Reiberger, Elisabeth Eder, M. Seif, M. Trauner, Bernhard K. Keppler, Peter Ferenci, Harald Hofer, G. Köllensperger, Thomas-Matthias Scherzer, Sandra Beinhardt, Sarah Theiner, AF Stättermayer, C. Willheim, Markus Peck-Radosavljevic, N. Rohr-Udilova
Publikováno v:
Journal of Hepatology. 66:S496-S497